BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Henlius 2022 H1 Results: Sharpen all-round edges, advance in evolution to Biopharma

In the first half of 2022, Henlius revenue reached approximately RMB1.289 billion, representing an increase of 103.5% YoY, which mainly benefited from...

August 19, 2022 | News

Hidden Pollution: Asia’s Rivers are Teeming with Pharmaceuticals

If we could monitor the presence of caffeine in rivers flowing through cities, we would probably notice a peak of concentration every early morning. ...

August 12, 2022 | News | By Francesco Ricciardi

Polyplus Introduces Transgene Plasmid Engineering Services for Optimized Viral Vector Manufacturing

Following the early 2022 acquisition of e-Zyvec, integration activities have focused on providing a deeper level of solutions support to customers. Using t...

August 03, 2022 | News

Merck Breaks Ground on Company’s First Lateral Flow Membrane Production Facility

New facility to manufacture the company’s Hi-Flow™ Plus lateral flow membrane used in rapid diagnostic test kit manufacturing, including Covi...

July 18, 2022 | News

Illumina is among the first companies in the world to receive approval of its net-zero emissions targets based on scientific criteria

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and network-based technologies, announced that it is one of the first group of ...

July 15, 2022 | News

Singapore Based SCG Cell Therapy Announces U.S FDA Clearance

ingapore-based SCG Cell Therapy Pte Ltd ("SCG") announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) ...

July 12, 2022 | News

Sobi to license loncastuximab tesirine from ADC Therapeutics

Sobi® announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and ...

July 11, 2022 | News

Sirio Pharma Announces Agreement to Acquire Best Formulations

Best Formulations, founded in 1984, is a leading contract manufacturer of softgels in North America. It engages in the manufacturing and commercialization ...

July 08, 2022 | News

Merck Initiates First Quality Control and Compliance Monitoring Summit in Malaysia

The summit was also a platform to discuss challenges, as well as hands-on training to improve laboratory skills, trouble-shooting methods, and data analysi...

July 07, 2022 | News

EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement

In this alliance, MTPC and EditForce aim to create potential novel pharmaceuticals for the specific CNS disease by utilizing the drug R&D know-how and ...

July 06, 2022 | News

New Shanghai office expands APAC operations for Eurofins DiscoverX.

The launch of Eurofins DiscoverX (Shanghai) Ltd. broadens its Asia-Pacific operations directly into the China market. This expansion es...

June 30, 2022 | News

Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies

Palleon Pharmaceuticals Inc., a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced a str...

June 29, 2022 | News

Antengene Announces Clinical Trial Collaboration with BeiGene

Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor Antengene Corporation Limited ("...

June 27, 2022 | News

Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...

June 24, 2022 | News

Stay Connected